||
In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases
Abstract
How metastases develop is not well understood and no genetic mutations have been reported as specific metastatic drivers. Here we have addressed the idea that epigenetic reprogramming by GLI-regulated pluripotent stemness factors promotes metastases. Using primary human colon cancer cells engrafted in mice, we find that transient expression of OCT4, SOX2, KLF4 +/- cMYC establishes an enhanced, pro-metastatic state in the primary tumor that is stable through sequential engraftments and is transmitted through clonogenic cancer stem cells. Metastatic reprogramming alters NANOG methylation and stably boosts NANOG and NANOGP8 expression. Metastases and reprogrammed EMT-like phenotypes require endogenous NANOG, but enhanced NANOG is not sufficient to induce these phenotypes. Finally, reprogrammed tumors enhance GLI2, and we show that GLI2high and AXIN2low, which are markers of the metastatic transition of colon cancers, are prognostic of poor disease outcome in patients. We propose that metastases arise through epigenetic reprogramming of cancer cells within primary tumors.
J Mol Cell Biol mjv034 first published online June 1, 2015 doi:10.1093/jmcb/mjv034
Keywords: metastases, epigenetic reprogramming, NANOG, GLI, cancer stem cells
This is an Open Access article. READ ME!
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-15 12:20
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社